Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults (vol 36, pg 6325, 2018)

被引：0
|
作者：
Brandon, Donald [1 ]
Kimmel, Murray [2 ]
Kuriyakose, Sherine O. [3 ]
Kostanyan, Lusine [4 ,5 ]
Mesaros, Narcisa [5 ]
机构：
[1] Calif Res Fdn, 4180 Ruffin Rd, San Diego, CA 92123 USA
[2] Accelovance Suite, Suite 102,1600 West Eau Gallie Blvd, Melbourne, FL USA
[3] GSK, 5 Embassy Links,Cunningham Rd, Bangalore 560052, Karnataka, India
[4] XPE Pharma & Sci, 19A Ave Edison, B-1300 Wavre, Belgium
[5] GSK, 20 Ave Fleming, B-1300 Wavre, Belgium
来源：
VACCINE | 2020年 / 38卷 / 12期
关键词：
D O I：
10.1016/j.vaccine.2020.01.082
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2746 / 2747
页数：2
相关论文
共 38 条
  • [1] Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults
    Brandon, Donald
    Kimmel, Murray
    Kuriyakose, Sherine O.
    Kostanyan, Lusine
    Mesaros, Narcisa
    VACCINE, 2018, 36 (42) : 6325 - 6333
  • [2] Booster vaccination of toddlers with reduced antigen content diphtheria-tetanus-acellular pertussis vaccine
    Nolan, Terry
    Ruff, Tilman A.
    Lambert, Stephen B.
    Buttery, Jim
    O'Grady, Kerry-Ann
    Streeton, Catherine
    Hoet, Bernard
    Bock, Hans L.
    VACCINE, 2009, 27 (18) : 2410 - 2413
  • [3] Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine
    Weston, Wayde
    Messier, Marc
    Friedland, Leonard R.
    Wu, Xiangfeng
    Howe, Barbara
    VACCINE, 2011, 29 (47) : 8483 - 8486
  • [4] High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine
    McIntyre, PB
    Turnbull, FM
    Egan, AM
    Burgess, MA
    Wolter, JM
    Schuerman, LM
    VACCINE, 2004, 23 (03) : 380 - 385
  • [5] Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults
    Grimprel, E
    von Sonnenburg, F
    Sänger, R
    Abitbol, V
    Wolter, JM
    Schuerman, LM
    VACCINE, 2005, 23 (28) : 3657 - 3667
  • [6] Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults
    Kovac, Martina
    Rathi, Niraj
    Kuriyakose, Sherine
    Hardt, Karin
    Schwarz, Tino F.
    VACCINE, 2015, 33 (22) : 2594 - 2601
  • [7] Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix™)
    Zhu, Fengcai
    Zhang, Shumin
    Hou, Qiming
    Zhang, Yiju
    Xu, Yinghua
    Ma, Xiao
    Lu, Xidong
    Pan, Hongxing
    Chen, Dengfeng
    Ramakrishnan, Gunasekaran
    Zhao, Richard
    Tang, Haiwen
    Van der Meeren, Olivier
    Bock, Hans L.
    HUMAN VACCINES, 2010, 6 (03): : 263 - 269
  • [8] Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: Immunogenicity 5 years post-vaccination
    McIntyre, Peter B.
    Burgess, Margaret A.
    Egan, Annemarie
    Schuerman, Lode
    Hoet, Bernard
    VACCINE, 2009, 27 (07) : 1062 - 1066
  • [9] The safety and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) booster vaccine in healthy Vietnamese children
    Dang Duc Anh
    Jayadeva, Girish
    Kuriyakose, Sherine
    Htay Htay Han
    VACCINE, 2016, 34 (37) : 4360 - 4363
  • [10] Immunogenicity and Safety after Booster Vaccination of Diphtheria, Tetanus, and Acellular Pertussis in Young Adults: an Open Randomized Controlled Trial in Japan
    Hara, Megumi
    Okada, Kenji
    Yamaguchi, Yuko
    Uno, Shingo
    Otsuka, Yasuko
    Shimanoe, Chisato
    Nanri, Hinako
    Horita, Mikako
    Ozaki, Iwata
    Nishida, Yuichiro
    Tanaka, Keitaro
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (12) : 1799 - 1804
1234